Skip to main content
Fig. 2 | World Journal of Surgical Oncology

Fig. 2

From: LINC00922 acts as a novel oncogene in gastric cancer

Fig. 2

Inhibition of LINC00922 suppresses GC progression in vitro. Sh-NC and sh-LINC00922 were transfected to MKN-45 and HGC-27. A The transfection efficiency was certified by qRT-PCR assay. B CCK-8 and C colony formation assays were performed to investigate the proliferation of LINC00922. D Wounding healing and E transwell assays were used to investigate the migration and invasion of LINC00922. F Flow cytometry assay was used to assess cell apoptosis of LINC00922. *P <0.05, **P < 0.01, ***P < 0.001 vs. sh-NC group

Back to article page